Research Program Award (R35 Clinical Trial Optional)

The Research Program Award (R35 Clinical Trial Optional) is a federal funding opportunity administered by the National Institutes of Health within the U.S. Department of Health and Human Services, specifically through the National Institute of Neurological Disorders and Stroke. This program is designed to provide long term, stable funding support to Program Directors and Principal Investigators conducting research aligned with the mission of advancing knowledge in neurological disorders and stroke. The opportunity is structured to reduce administrative burden and enable researchers to focus more directly on scientific discovery, mentorship, and laboratory leadership. The primary purpose of this program is to support investigators in pursuing ambitious, long term research goals that may not fit within the constraints of shorter duration or narrowly scoped grants. By offering flexible funding not tied to specific aims, the program allows investigators to adapt their research direction as new opportunities arise. This approach is intended to foster innovation, support groundbreaking discoveries, and encourage sustained progress in neuroscience and related biomedical fields. Funding under this opportunity supports a wide range of research activities that fall within the mission of the National Institute of Neurological Disorders and Stroke. Allowable uses include laboratory research, personnel support, and mentorship activities for trainees such as students and postdoctoral researchers. Projects must align with the institute mission, and research that falls under the purview of other NIH institutes or centers is not eligible for support through this program. No cost sharing or matching requirement is specified, which lowers financial barriers for applicants. Eligibility for this opportunity is broad and inclusive, encompassing a wide range of entity types including federal, state, and local government agencies, institutions of higher education, nonprofit organizations, for profit entities, tribal governments, and international organizations. This inclusivity supports diverse participation across sectors and geographies, including both domestic and non domestic institutions. Applicants are expected to demonstrate capacity to conduct sustained research programs and contribute to the advancement of neuroscience. The application process for this opportunity is not yet open, as it is currently forecasted. The notice indicates that a formal funding announcement will be published at a later date, and potential applicants are encouraged to begin preparing by forming collaborations and developing research concepts. Once released, the application process is expected to follow standard NIH submission procedures, which typically include proposal narratives, budgets, and supporting documentation submitted through federal grant systems. The timeline provided indicates an estimated application posting date in April 2026, with an application deadline in July 2026, and anticipated award and project start dates in March 2027. At the time of analysis, the application deadline has passed, and the opportunity is no longer accepting applications. There is no explicit indication of recurring cycles, though similar NIH programs are often reissued periodically. Applicants interested in future opportunities should monitor NIH announcements for subsequent funding cycles. For additional information or inquiries, applicants may contact the program directly via the provided email address. This contact serves as the primary point of communication for clarifying program details and preparing for future application opportunities.